Discover how the emerging global generics market has advanced over the last 18 months and what this means for the pharma industry.
This report updates you on the key political, legislative, regulatory, operational and commercial developments affecting generic drugs in the major markets over the last 18 months, enabling you to respond to the opportunities and challenges this emerging market presents.
Use this report to:
• Gain insights into the continuing global debate over patents, market exclusivity, drug pricing and compulsory licensing in light of the TRIPS agreement and Doha Declaration
• Learn about the key issues affecting the industry such as tensions over authorised generics and “reverse” settlements, and how these impact your market
• Assess EU harmonisation of the generics market, usage patents, cost-containment and new pricing paradigms and use this knowledge to plan accordingly
• Evaluate the potential impact of biosimilars on your market and what the current trend for consolidation amongst generics manufacturers means for the future.
New Dynamics and Challenges in the Generics Market 2007 market research report provides a detail review of the sector with 308 pages.